Description: Presented at May 1985 Spring Meeting. This session discussed: Overview of the valuation actuary's role, Product development implications, Actuarial profession implications, Implications for regulators, Implications for insurance company management.

Description: In-depth discussion about HIV and AIDS: [1] mortality-study results, [2] risk-classification challenges, including regulatory issues, [3] mortality-projection methods, [4] significant pricing and valuation – STAT and GAAP – information, and [5] overall industry implications. From the 1988 Record of Society of Actuaries, Vol. 14, No. 4A.